Products with Anticancer bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN1314 | 2,3,24-Trihydroxy-12-ursen-28-oic acid |
| 2α,3α,24-Trihydroxyurs-12-en-28-oic acid, a triterpenoid phytoalexin, shows antifungal activity against the fungus mentioned. It also shows in vitro cytotoxic activity against tumor cell lines including PLC,Hep3B,HepG2,HeLa,SW480,MCF-7 and Bel7402. | |
| BCN1322 | 3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid |
| 1. 3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid inhibits the MRCKα kinase with Kd50 of 3.0 uM, it also inhibits the MRCKβ kinase with Kd50 of 3.2 uM; the role of Kinases in cancer onset and progression has made kinases a target for the control of some cancers, suggests that it may possess anticancer activity. | |
| BCN1323 | threo-Guaiacylglycerol beta-coniferyl ether |
| 1. Threo-Guaiacylglycerol beta-coniferyl ether displays significant inhibitory effects on NO production. | |
| BCN1338 | 3-Oxo-24,25,26,27-tetranortirucall-7-en-23,21-olide |
| 1. 3-Oxo-24,25,26,27-tetranortirucall-7-ene-23(21)-lactone shows significant inhibitory activities against human cancer cell lines in vitro. | |
| BCN1381 | 3-O-Acetyl-11-keto-beta-boswellic acid |
| 3-O-Acetyl-11-keto-beta-boswellic acid inhibits 5-lipoxygenase product formation with an IC(50) of 1.5 m muM. | |
